Clinical Trial Update: A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin Study [Phase 2]

View source ↗

Summary

Phase 2 trial update of brentuximab vedotin in patients who previously participated in a brentuximab vedotin study, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)

Snippet

Sponsor: Seagen Inc. | Conditions: Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic | Phase 2 | Status: COMPLETED | Results posted: 2014-05-26